Hercules Capital, Inc. (HCXY)
| Market Cap | 2.91B -5.6% |
| Revenue (ttm) | 554.52M +12.8% |
| Net Income | 329.11M +49.3% |
| EPS | 1.78 +33.8% |
| Shares Out | 184.37M |
| PE Ratio | 8.83 |
| Forward PE | 7.86 |
| Dividend | $1.56 (6.23%) |
| Ex-Dividend Date | Jul 15, 2026 |
| Volume | 3,985 |
| Open | 25.05 |
| Previous Close | 25.04 |
| Day's Range | 25.05 - 25.15 |
| 52-Week Range | 24.36 - 25.71 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 30, 2026 |
About HCXY
Hercules Capital, Inc. is a business development company. The firm specializing in providing private equity, venture debt, and growth capital to privately held venture capital-backed companies at all stages of development from mid venture to expansion stage including select publicly listed companies and select special opportunity companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management ... [Read more]
News
4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital
EMERYVILLE, Calif., June 29, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted t...
Hercules Capital Transcript: AGM 2026
The meeting covered strong 2025 and Q1 2026 financial results, record new commitments, and a new supplemental dividend. All six shareholder proposals passed, including director election and plan amendments. The company highlighted its diversified portfolio and conservative balance sheet.
Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc.
- Up to $125 million in additional borrowing capacity provides further strategic flexibility - - $50 million of additional capacity funded at amendment closing - WALTHAM, Mass., June 17, 2026 (GLOBE N...
Beren Therapeutics Secures $300M Financing to Support the Potential Commercial Launch of Adrabetadex and Long-Term Care Initiatives for Infantile-Onset Niemann-Pick Disease, Type C
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Beren Therapeutics P.B.C., the parent company of Mandos LLC and a leader in cholesterol trafficking biology and cyclodextrin-based therapeutics, today announced...
HTGC Lawsuit Alleges CEO Allegedly Certified Misleading Statements - Hercules Capital Investors Face Losses Following CEO Allegedly Certified Misleading Statements: SueWallSt
Important Information Regarding Section 20(a) Individual Liability Claims Against Hercules Capital Officers NEW YORK, May 7, 2026 /PRNewswire/ -- SueWallSt alerts investors in Hercules Capital, Inc. (...
Hercules Capital Announces Date of 2026 Annual Meeting of Stockholders
SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), will conduct its 2026 Annual Meeting of Stockholders by virtual meeting on T...
Hercules Capital Earnings Call Transcript: Q1 2026
Record Q1 originations and investment income were achieved amid market volatility, with strong credit quality, robust liquidity, and a balanced portfolio across life sciences and technology. Elevated prepayments from M&A are expected in Q2, supporting continued capital redeployment.
Hercules Capital Slides: Q1 2026
Hercules Capital has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 5, 2026.
Hercules Capital Earnings release: Q1 2026
Hercules Capital released its Q1 2026 earnings on May 5, 2026, summarizing the period's financial results.
Hercules Capital Quarterly report: Q1 2026
Hercules Capital has published its Q1 2026 quarterly earnings report on May 5, 2026.
Hercules Capital Reports First Quarter 2026 Financial Results
SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty financing provider to innovative venture, ...
Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital
THE WOODLANDS, Texas, May 04, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that it has entered into a loan facility with Hercules Capital, Inc. (NYSE: HTGC) th...
Senseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 Million
GERMANTOWN, Md., May 04, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the design, development and commercialization of glucose monitoring p...
Hercules Capital Proxy statement: Proxy filing
Hercules Capital filed a proxy statement on May 4, 2026, providing details for shareholder voting and corporate governance matters.
Hercules Capital Enters Next Phase of Growth with Expanded Leadership Team
SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty financing provider to innovative venture, ...
HTGC Lawsuit Alleges Executives Allegedly Misled Shareholders - Hercules Capital Investors Face Losses Following Executives Allegedly Misled Shareholders: SueWallSt
Notice to Pension Funds, Asset Managers, and Fiduciaries Holding HTGC During the Class Period NEW YORK, April 30, 2026 /PRNewswire/ -- Institutional investors holding positions in Hercules Capital, In...
Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the First Quarter 2026
SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty financing provider to innovative, venture,...
HTGC Lawsuit Alleges Company Allegedly Copied Deal Sourcing Process - Hercules Capital Investors Face Losses Following Company Allegedly Copied Deal Sourcing Process: SueWallSt
Alert: Claims Focus on Alleged Deficiencies in Deal Origination and Portfolio Valuation Operations NEW YORK, April 23, 2026 /PRNewswire/ -- SueWallSt reminds purchasers of Hercules Capital, Inc. (NYSE...
Hercules Capital Proxy statement: Proxy filing
Hercules Capital filed a proxy statement on April 23, 2026, providing details for shareholder voting and corporate governance matters.
Hercules Capital Proxy statement: Proxy filing
Hercules Capital filed a proxy statement on April 23, 2026, providing details for shareholder voting and corporate governance matters.
Hercules Capital Announces Date for Release of First Quarter 2026 Financial Results and Conference Call
SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty financing provider to innovative venture, ...
HTGC Lawsuit Alleges Hercules Allegedly Misclassified Software Debt Exposure - Hercules Capital Investors Face Losses Following Hercules Allegedly Misclassified Software Debt Exposure: SueWallSt
Time-Sensitive: Allegations Focus on Hidden Software Debt Concentration and Distressed Valuations NEW YORK, April 16, 2026 /PRNewswire/ -- "Investors deserve transparency about material risks that cou...
Hercules Capital Sets New Record with All-Time High New Debt and Equity Commitments
SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty financing provider to innovative venture, ...
Hercules Capital Receives a BBB (high) Affirmed Investment Grade Corporate and Credit Rating from Morningstar DBRS
SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty financing provider to innovative venture, ...